摘要
Clinical sorafenib treatment could activate C-X-C receptor type 4 (CXCR4)/stromal source factor-1 alpha (SDF-1 alpha) axis to aggravate intra-tumoral hypoxia of hepatocellular carcinoma (HCC), which further leads to progression, invasion, metastasis, and immunosuppression of tumors and in return causes resistance to sorafenib therapy. Therefore, a multi-functional oxygen delivery nanoplatform was rationally constructed based on an oxygen-saturated perfluorohexane (PFH)-cored liposome, with the CXCR4 antagonist LFC131 peptides modifying on the surface to simultaneously deliver sorafenib and the CSF1/CSF1R inhibitor PLX3397 (named PFH@LSLP) for sorafenib-resistant HCC treatment. The PFH@LSLP was developed to overcome sorafenib resistance by synergistic effects of the following 3 roles: 1) the O-2-saturated PFH core could alleviate the tumor hypoxia by O-2 supply; 2) the LFC131 peptide recognized the hypoxia-related overexpressed CXCR4 and then blocked SDF-1 alpha/CXCR4 axis to re-sensitize the HCC cells to sorafenib; 3) PLX3397 activated the immune responses via inhibiting the CSF1/CSF1R pathway in TAMs, further enhanced CD8(+) T cell infiltration to reverse immunosuppression in tumors. Antitumor performance on H22 tumor-bearing mice and HCC patient-derived tumor xenograft (PDX) model showed that PFH@LSLP could overcome sorafenib resistance by synergistic effect of hypoxia attenuation, resistance-related gene regulation, and immune-microenvironment modification.
学科与关键词
- Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapyHuang, Linzhuo; Xu, Rui; Li, Weirong; Lv, Li; Lin, Chunhao; Yang, Xianzhu; Yao, Yandan; Saw, Phei Er*; Xu, Xiaoding*Acta Biomaterialia, 2023, 162: 98-109.被引 3
- Near-Infrared Light Laser-Triggered Release of Doxorubicin and Sorafenib from Temperature-Sensitive Liposomes for Synergistic Therapy of Hepatocellular CarcinomaPeng, Yuan*; Su, Zhenwei; Wang, Xin; Wu, Teng; Xiao, Hong; Shuai, Xintao; Lan, Yue*Journal of Biomedical Nanotechnology, 2020, 16(9): 1381-1393.被引 6
- Sorafenib-Based Drug Delivery Systems: Applications and PerspectivesWang, Lingyun*; Chen, Meihuan; Ran, Xueguang; Tang, Hao; Cao, DerongPolymers, 2023, 15(12): 2638.
